Literature DB >> 16247935

Rapid LC/MS/MS method development for drug discovery.

Xiaoying Xu1, Jing Lan, Walter A Korfmacher.   

Abstract

Mesh:

Year:  2005        PMID: 16247935

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


× No keyword cloud information.
  6 in total

Review 1.  Multi-dimensional liquid chromatography in proteomics--a review.

Authors:  Xiang Zhang; Aiqin Fang; Catherine P Riley; Mu Wang; Fred E Regnier; Charles Buck
Journal:  Anal Chim Acta       Date:  2010-02-06       Impact factor: 6.558

2.  Validation of a sensitive UHPLC-MS/MS method for cytochrome P450 probe substrates caffeine, tolbutamide, dextromethorphan, and alprazolam in human serum reveals drug contamination of serum used for research.

Authors:  Luying Chen; Richard B van Breemen
Journal:  J Pharm Biomed Anal       Date:  2019-11-10       Impact factor: 3.935

3.  Identification and counting of carbonyl and hydroxyl functionalities in protonated bifunctional analytes by using solution derivatization prior to mass spectrometric analysis via ion-molecule reactions.

Authors:  Jayalakshmi Somuramasami; Brian E Winger; Todd A Gillespie; Hilkka I Kenttämaa
Journal:  J Am Soc Mass Spectrom       Date:  2009-12-04       Impact factor: 3.109

4.  Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.

Authors:  György Vas; Karina Conkrite; Wendy Amidon; Yueming Qian; Katalin Bánki; András Perl
Journal:  J Mass Spectrom       Date:  2006-04       Impact factor: 1.982

5.  Proteomics in the characterization of adipose dysfunction in obesity.

Authors:  David Brockman; Xiaoli Chen
Journal:  Adipocyte       Date:  2012-01-01       Impact factor: 4.534

6.  Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis.

Authors:  Thamir M Alshammari; Ahmed Ali Al-Hassan; Taibi B Hadda; Mohamad Aljofan
Journal:  Saudi Pharm J       Date:  2015-02-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.